A series of highly interactive 2-day seminars delivered by Malvern Instruments, which encompassed expert presentations and 'up close' practical workshops showcasing the latest in nanoparticle characterization technology, have been widely praised by attendees.
Accutest Laboratories recently completed a first-to-file study for the fixed dose combination of Memantine 28 mg ER and Donepezil hydrochloride ten mg capsule in a record setting time of five days. This included volunteer screening, clinical, analytical, QA and report writing activities and submission.
The Haselmeier Group has decided to reinforce and reorganise its Executive Board. Mr. Gert Weber has been nominated by the Board of Directors of Medico Invest AG as Chief Executive Officer (CEO) of the Haselmeier Group. This nomination is effective starting July 1st, 2015. Mr. Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions, the last being Managing Director and Vice President responsible for Operations and Information Technology (IT) at Avnet TS (former Magirus Group). With his experience and expertise, Mr. Weber shall contribute to strengthen Haselmeier's position and performance in the medical device industry and beyond.
Safety and medical services firm unveils new name and branding at opening of DIA Annual Meeting in Washington, DC.
PRA Health Sciences (PRA) is pleased to announce that it was once again recognized as the Best Clinical Company of the Year. PRA received the award at the PharmaTimes Clinical Researcher of the Year Americas ceremony in Cary, North Carolina. This award follows PRA’s recognition as the Best International Clinical Company of the Year which was announced earlier this year in London.
PRA Health Sciences, a leading global contract research organization, today announced its new Predictivv™ platform, the beginning of an entirely new approach on the role technology will play in the future of clinical development. The Predictivv™ platform will be a fully integrated solution for designing, planning and optimizing the management of global clinical studies. Designed around a unified platform that harmonizes data, processes, and people across every aspect of a clinical study, Predictivv™ will enable unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.
The design, development and manufacturing of a successful auto injector project requires not only the seamless collaboration between the biopharmaceutical company and key partners, but also robust design and manufacturing capabilities that can ultimately reflect the desired device characteristics. With industrial design often the initial starting point of a project, possessing a strong in-house industrial team can mean more efficient communication with production teams which can lead to faster prototyping and design verification.
SanaClis has underlined its credentials as a leading potential partner for pharma or biotech organizations that needs clinical research support in Central and Eastern Europe with an impressive showing in the latest Nice Insight ‘Top Ten’ survey.
Seattle’s Hub for Industry-Driven Nanotechnology Education (Seattle, USA), an imaginative educational body with a flexible and highly productive model for nanotechnician training, has identified dynamic light scattering particle sizing as an essential analytical technique, investing in a Zetasizer Nano from Malvern Instruments.
Try Our New Phosphine "pi-allyl" Palladium Catalysts For Unprecedented Results.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.